Targeted NGS panel of 648 genes for Solid Tumors and Hematology
Welcome to the future of genomic driven cancer care.
Genomic footprint is used to personalize and optimize cancer treatments. Our genomic test investigate patients tumor at the molecular level to identify best treatment options for each and every patient.
It's about time!
Tumor Mutational Burden testing is now a standard component of the xT 648 Profile. It measures the quantity of somatic mutations, and tumors with higher TMB have an increased likelihood of response to immunotherapy.
Microsatellite Instability Analysis is routinely performed with Colorectal, Endometrial, Esophageal, Gastric, GI Predictive, Ovarian, and Pancreas Profiles, and is included in xT 648 Gene Panel.